2009
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1007/s00431-008-0904-x
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/19104834
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1432-1076[electronic]
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_A3D492EF77756
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
A.S. de Buys Roessingh et al., « Congenital diaphragmatic hernia: current status and review of the literature. », Serveur académique Lausannois, ID : 10.1007/s00431-008-0904-x
Treatment of congenital diaphragmatic hernia (CDH) challenges obstetricians, pediatric surgeons, and neonatologists. Persistent pulmonary hypertension (PPHT) associated with lung hypoplasia in CDH leads to a high mortality rate at birth. PPHT is principally due to an increased muscularization of the arterioles. Management of CDH has been greatly improved by the introduction of prenatal surgical intervention with tracheal obstruction (TO) and by more appropriate postnatal care. TO appears to accelerate fetal lung growth and to increase the number of capillary vessels and alveoli. Improvement of postnatal care over the last years is mainly due to the avoidance of lung injury by applying low peak inflation pressure during ventilation. The benefits of other drugs or technical improvements such as the use of inhaled nitric oxide or extracorporeal membrane oxygenation (ECMO) are still being debated and no single strategy is accepted worldwide. Despite intensive clinical and experimental research, the treatment of newborn with CDH remains difficult.